CHINA PHARMA HOLDINGS, INC. Cash
CHINA PHARMA HOLDINGS, INC. (CPHI) had Cash of $1.18 million as of 2021-09-09, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2024-04-01
- 2021-09-09: Cash $1.18M.
- 2021-06-30: Cash $1.75M.
- 2020-12-23: Cash $864.48K.
- 2020-06-30: Cash $2.04M.
| Period end | Cash |
|---|---|
| 2021-09-09 | $1.18M 10-K · filed 2024-04-01 |
| 2021-06-30 | $1.75M 10-Q · filed 2021-08-13 |
| 2020-12-23 | $864.48K 10-K · filed 2024-04-01 |
| 2020-06-30 | $2.04M 10-Q · filed 2021-08-13 |
| 2017-03-31 | $2.52M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $2.67M 10-Q · filed 2017-05-11 |
| 2016-09-30 | $3.65M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $6.29M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $7.26M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $6.25M 10-K · filed 2017-03-31 |
| 2015-09-30 | $5.74M 10-Q · filed 2015-12-28 |
| 2015-06-30 | $4.55M 10-Q · filed 2015-12-28 |
| 2015-03-31 | $5.27M 10-Q · filed 2015-12-28 |
| 2014-12-31 | $5.30M 10-K · filed 2016-03-30 |
| 2014-09-30 | $4.27M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $4.43M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $5.29M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $5.99M 10-K · filed 2015-12-28 |
| 2013-09-30 | $4.51M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $2.52M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $4.75M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $4.03M 10-K · filed 2014-03-20 |
| 2012-03-31 | $3.32M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $4.05M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |